DV
Dividend Vision

GNLX — Genelux Corporation Common Stock

Genelux Corporation Common Stock (GNLX)

Total return is -55.4% over the past 3.5 years, 156.0 points behind SPY at 100.6%. Its deepest 1-year drawdown was 72.1%.

Genelux Corporation Common Stock is an equity fund holding the common stock of Genelux Corporation, a biotechnology company. The fund does not currently pay distributions, making it a non-dividend-paying equity holding with no yield profile. This fund appeals primarily to growth-oriented investors seeking exposure to the biotechnology sector rather than those focused on generating current income.

GNLX key facts

Asset type
Stock
Asset class
Equity
Inception date
01/26/2023
Last close
$2.74
Market cap
$128,691,992
Average volume
462788.0
Beta
0.571
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.85